Allegro gets $4 million in venture financing

Allegro Diagnostics announced today the completion of $4 million in Series A financing.

The Boston company is using intellectual property that originated from the Pulmonary Center at the Boston University School of Medicine in its efforts to develop products that can detect lung cancer earlier than current diagnostic tests on the market.

Kodiak Venture Partners of Waltham led the round and was joined by Catalyst Health Ventures of Newton and BU, the company said.

According to the American Cancer Society, more than 200,000 new cases of lung cancer are diagnosed each year in the United States.